Daytime somnolence in patients with Parkinson's disease

Parkinsonism & Related Disorders
C C. SanjivD B. Calne

Abstract

We studied daytime sleepiness in 160 patients with Parkinson's disease and 40 normal subjects. We compared the prevalence of daytime sleepiness in patients who were taking levodopa alone, levodopa with bromocriptine, levodopa with ropinirole, and levodopa with pramipexole. We found that (1) all these anti-Parkinson drugs can cause daytime sleepiness; (2) 'dozing off' correlated highly with 'falling asleep without warning'; (3) after statistical adjustment for confounding variables there was no significant difference among the risks for any of these anti-Parkinson drugs causing daytime somnolence.

References

Jan 1, 1992·Annals of Neurology·D B CalneC Lee
Feb 6, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·O RascolF Stocchi
Apr 25, 2000·Lancet·A H Schapira
Apr 25, 2000·Lancet·J J FerreiraO Rascol
Apr 2, 2010·Sleep & Breathing = Schlaf & Atmung·Yong Won ChoMurray W Johns

❮ Previous
Next ❯

Citations

Mar 9, 2006·Current Neurology and Neuroscience Reports·David B Rye
Apr 3, 2003·Current Treatment Options in Neurology·David B. Rye
Mar 23, 2004·Sleep Medicine·Raffaele ManniClaudio Pacchetti
May 1, 2002·Clinical Neuropharmacology·Anette V Nieves, Anthony E Lang
Apr 19, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J J FerreiraO Rascol
May 31, 2003·CNS Drugs·Theresa A Zesiewicz, Robert A Hauser
Aug 28, 2002·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A Jon Stoessl
Dec 10, 2015·Expert Opinion on Drug Safety·Roberto CeravoloUbaldo Bonuccelli
Jul 3, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·K Ray ChaudhuriChristine Brefel-Courbon
Mar 7, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Birgit HöglWerner Poewe
Jan 30, 2010·Parkinsonism & Related Disorders·Ryan J Uitti
Dec 1, 2008·Revue neurologique·C Monaca
Mar 7, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Charles H AdlerJudy Tiede
Apr 28, 2004·Parkinsonism & Related Disorders·Joseph H Friedman, Kelvin L Chou
Oct 7, 2006·Sleep Medicine·Margaret ParkDavid A Bennett
Feb 18, 2003·Fundamental & Clinical Pharmacology·E K Tan
Mar 8, 2008·Expert Opinion on Drug Safety·Ubaldo Bonuccelli, Roberto Ceravolo
Apr 6, 2002·Expert Opinion on Pharmacotherapy·Donald B Calne
Sep 2, 2008·Biochimica Et Biophysica Acta·Haeman JangRichard Jay Smeyne

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.